Gleason Score News and Research

RSS
Length of telomere may help determine prostate cancer patient's prognosis

Length of telomere may help determine prostate cancer patient's prognosis

New ultra-specific test now available for prostate cancer

New ultra-specific test now available for prostate cancer

Long-term hormonal therapy has no additional benefits in men with intermediate-risk prostate cancer

Long-term hormonal therapy has no additional benefits in men with intermediate-risk prostate cancer

Gene panel predicts low-risk prostate cancer fate

Gene panel predicts low-risk prostate cancer fate

Three-gene biomarker can help determine treatment option for early prostate cancer

Three-gene biomarker can help determine treatment option for early prostate cancer

Pathologist experience critical for accurate Gleason score

Pathologist experience critical for accurate Gleason score

Viewpoints: Health law rollout needs a better salesman; the overhaul is shifting the economy to part-timers

Viewpoints: Health law rollout needs a better salesman; the overhaul is shifting the economy to part-timers

New clinic focuses on men with fast-growing prostate cancer

New clinic focuses on men with fast-growing prostate cancer

Study: Active surveillance does not appear to be good idea for black men with prostate cancer

Study: Active surveillance does not appear to be good idea for black men with prostate cancer

Study examines increased use of new technologies for prostate cancer treatment

Study examines increased use of new technologies for prostate cancer treatment

Some aggressive forms of prostate cancer have similar genetic origins

Some aggressive forms of prostate cancer have similar genetic origins

New risk classification system proposed for prostate cancer

New risk classification system proposed for prostate cancer

New risk classification system proposed for prostate cancer

New risk classification system proposed for prostate cancer

Prostate cancer prognosis tables: an interview with Dr John B. Eifler, Brady Urological Institute of Johns Hopkins

Prostate cancer prognosis tables: an interview with Dr John B. Eifler, Brady Urological Institute of Johns Hopkins

Prostate tissue androgen content predicts ADT outcome

Prostate tissue androgen content predicts ADT outcome

Focal laser ablation uses targeted heat to burn away cancerous cells in prostate

Focal laser ablation uses targeted heat to burn away cancerous cells in prostate

Predictive value of prostate cancer gene 3 validated

Predictive value of prostate cancer gene 3 validated

Cutting down on fried food could lower prostate cancer risk

Cutting down on fried food could lower prostate cancer risk

Prediagnostic androgen level not linked to prostate cancer outcome

Prediagnostic androgen level not linked to prostate cancer outcome

Dutasteride decreases risk of biopsy detectable prostate cancer by 22.8%

Dutasteride decreases risk of biopsy detectable prostate cancer by 22.8%